Application 021166

Type
NDA
Sponsor
ASCEND THERAPS US

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001ESTROGELESTRADIOLGEL;TOPICAL0.06%NoNo
002ESTROGELESTRADIOLGEL, METERED;TRANSDERMAL0.06% (1.25GM/ACTIVATION)YesYes

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
17139-613EstroGelestradiolASCEND Therapeutics US, LLCNDACurrent
17139-617EstroGelestradiolASCEND Therapeutics US, LLCNDACurrent
17139-617EstroGelestradiolASCEND Therapeutics US, LLCNDACurrent
17139-617EstroGelestradiolASCEND Therapeutics US, LLCNDACurrent
17139-617EstroGelestradiolASCEND Therapeutics US, LLCNDACurrent
17139-617EstroGelestradiolASCEND Therapeutics US, LLCNDACurrent
17139-617EstroGelestradiolASCEND Therapeutics US, LLCNDACurrent
17139-617EstroGelestradiolASCEND Therapeutics US, LLCNDACurrent

Documents

DocumentTitleSubmission typeSubmission no.DateStorage
775780SUPPL 192024-02-20Cached in FDA.report object storage
775550SUPPL 192024-02-16Cached in FDA.report object storage
749790SUPPL 182023-08-03Cached in FDA.report object storage
749740SUPPL 182023-08-02Cached in FDA.report object storage
694640SUPPL172021-12-03Cached in FDA.report object storage
694390SUPPL172021-12-01Cached in FDA.report object storage
502750SUPPL152017-11-02Cached in FDA.report object storage
269560SUPPL102014-03-27Cached in FDA.report object storage
145450SUPPL102014-03-27Cached in FDA.report object storage
145440SUPPL72008-01-30Cached in FDA.report object storage
269550SUPPL72008-01-29Cached in FDA.report object storage
45190SUPPL52007-07-30Cached in FDA.report object storage
362540SUPPL52007-07-27Cached in FDA.report object storage
419990ORIG12005-06-23FDA source fallback
269540SUPPL12004-09-15FDA source fallback
145430ORIG12004-04-05FDA source fallback
45180ORIG12004-03-02FDA source fallback